Literature DB >> 21093323

Hes1 is a critical but context-dependent mediator of canonical Notch signaling in lymphocyte development and transformation.

Agnieszka A Wendorff1, Ute Koch, F Thomas Wunderlich, Silvia Wirth, Christelle Dubey, Jens C Brüning, H Robson MacDonald, Freddy Radtke.   

Abstract

Although canonical Notch signaling regulates multiple hematopoietic lineage decisions including T cell and marginal zone B cell fate specification, the downstream molecular mediators of Notch function are largely unknown. We showed here that conditional inactivation of Hes1, a well-characterized Notch target gene, in adult murine bone marrow (BM) cells severely impaired T cell development without affecting other Notch-dependent hematopoietic lineages such as marginal zone B cells. Competitive mixed BM chimeras, intrathymic transfer experiments, and in vitro culture of BM progenitors on Delta-like-expressing stromal cells further demonstrated that Hes1 is required for T cell lineage commitment, but dispensable for Notch-dependent thymocyte maturation through and beyond the beta selection checkpoint. Furthermore, our data strongly suggest that Hes1 is essential for the development and maintenance of Notch-induced T cell acute lymphoblastic leukemia. Collectively, our studies identify Hes1 as a critical but context-dependent mediator of canonical Notch signaling in the hematopoietic system.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21093323     DOI: 10.1016/j.immuni.2010.11.014

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  59 in total

1.  HES1 opposes a PTEN-dependent check on survival, differentiation, and proliferation of TCRβ-selected mouse thymocytes.

Authors:  Gladys W Wong; Gisele C Knowles; Tak W Mak; Adolfo A Ferrando; Juan Carlos Zúñiga-Pflücker
Journal:  Blood       Date:  2012-05-30       Impact factor: 22.113

2.  A HESitant decision for T cells.

Authors:  Alexandra Bortnick; Cornelis Murre
Journal:  Nat Immunol       Date:  2013-12       Impact factor: 25.606

3.  Leukemia stem cells in T-ALL require active Hif1α and Wnt signaling.

Authors:  Vincenzo Giambra; Catherine E Jenkins; Sonya H Lam; Catherine Hoofd; Miriam Belmonte; Xuehai Wang; Sam Gusscott; Deanne Gracias; Andrew P Weng
Journal:  Blood       Date:  2015-05-01       Impact factor: 22.113

Review 4.  Critical roles of NOTCH1 in acute T-cell lymphoblastic leukemia.

Authors:  Hudan Liu; Mark Y Chiang; Warren S Pear
Journal:  Int J Hematol       Date:  2011-08-05       Impact factor: 2.490

Review 5.  Developmental gene networks: a triathlon on the course to T cell identity.

Authors:  Mary A Yui; Ellen V Rothenberg
Journal:  Nat Rev Immunol       Date:  2014-08       Impact factor: 53.106

Review 6.  Ex vivo expansion of human hematopoietic stem and progenitor cells.

Authors:  Ann Dahlberg; Colleen Delaney; Irwin D Bernstein
Journal:  Blood       Date:  2011-03-23       Impact factor: 22.113

7.  Genome-wide analysis reveals conserved and divergent features of Notch1/RBPJ binding in human and murine T-lymphoblastic leukemia cells.

Authors:  Hongfang Wang; James Zou; Bo Zhao; Eric Johannsen; Todd Ashworth; Hoifung Wong; Warren S Pear; Jonathan Schug; Stephen C Blacklow; Kelly L Arnett; Bradley E Bernstein; Elliott Kieff; Jon C Aster
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-07       Impact factor: 11.205

8.  Early T-cell progenitors are the major granulocyte precursors in the adult mouse thymus.

Authors:  Maria Elena De Obaldia; J Jeremiah Bell; Avinash Bhandoola
Journal:  Blood       Date:  2012-11-14       Impact factor: 22.113

Review 9.  Regulation of innate and adaptive immunity by Notch.

Authors:  Freddy Radtke; H Robson MacDonald; Fabienne Tacchini-Cottier
Journal:  Nat Rev Immunol       Date:  2013-05-13       Impact factor: 53.106

10.  β-Selection-induced proliferation is required for αβ T cell differentiation.

Authors:  Taras Kreslavsky; Michael Gleimer; Masaki Miyazaki; Yoon Choi; Etienne Gagnon; Cornelis Murre; Piotr Sicinski; Harald von Boehmer
Journal:  Immunity       Date:  2012-11-16       Impact factor: 31.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.